Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby ...

HIV weakens the cells that usually fight off infection. Over time, especially if you don’t take your HIV medicines, your body may have a harder time fighting off infections that cause rashes.

Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

2024 — An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain ...

Here, Olari et al show that alpha-synuclein enhances HIV-1 entry and replication in human T ... cells in humanized mice. Mutations of CCR5 have been linked to improved outcome to HIV infection.

HIV is a virus that damages cells in the immune system and disrupts ... Approximately 1 million people are infected with HIV worldwide each year, and there is no cure. But many medications are ...

Repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus ...

Importantly, the interaction between CXCR4 and its ligand SDF-1 is involved in various disease conditions, such as cancer cell metastasis ... diseases as well as HIV infection.